Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Donor cells from new source ignored by the immune system

18.06.2003


Transplant research takes a hopeful step



Researchers at Kansas State University have successfully transplanted cells from one species to another without triggering an immune system rejection response or requiring drugs to suppress the immune system.

This hopeful news for transplant medicine is reported in the online edition of the journal Experimental Neurology, published by Elsevier.


Researchers transplanted umbilical cord matrix stem cells from a pig into the brain of a live rat, and for reasons they as yet do not understood, the recipient’s immune system did not detect nor reject the foreign cells, which survived for more than six weeks. No drugs were used to suppress the immune response.

A subset of the transplanted stem cells responded to the chemical environment of the brain and began to develop as nervous system cells. This transition of cell type in a living animal is the first indication that umbilical cord matrix stem cells could be useful therapeutically.

"Specifically, the umbilical cord matrix cell source may offer us a basis for treating nervous system disorders like Parkinson’s disease," said neuroscientist Mark Weiss, lead investigator and first author of the study.

Developing effective treatments for Parkinson’s and other nervous system disorders depends on scientists identifying a source of neural progenitor cells that can be transplanted without complications.

"Transplantation of Porcine Umbilical Cord Matrix Cells into the Rat Brain" is co-authored with veterinary and animal science researchers Kathy Mitchell, J.E. Hix, S. Medicetty, S.Z. El-Zarkouny, David Grieger and Deryl Troyer.

"We are reporting three lines of evidence indicating that stem cells from the umbilical cord matrix do not trigger an immune system response when they are transplanted across species," said Weiss. "We do not understand yet what enables the donor UCM cells to exist below the radar of the recipient’s immune system," he added.

Rejection of transplanted material is an immune system response that poses a serious limitation for successful cell and organ transplants.

To grapple with this vexing problem, transplant recipients typically receive massive doses of immunosuppressive drugs in the hope of buying time for grafted cell or organ to survive and take hold.

Pig umbilical cord matrix cells appear to be ignored by the immune system when implanted into rat brain, which makes the cells potentially useful as future therapy. In similar studies, K-State researchers are now testing human umbilical cord matrix cells for transplant suitability. Evidence already exists that the human umbilical cord matrix cells can differentiate into nervous system tissue.

In a January 2003 paper in the journal Stem Cells, the K-State team reported that umbilical cord matrix cells from both animal and human are a type of stem cell that can be induced in vitro to differentiate into neurons and glia, the primary nervous system tissues.

Based on that discovery, the current project was designed to answer two important questions -- could umbilical cord matrix cells survive transplantation from one species into another, and if they survive, could they differentiate from donor stem cell status to become nervous system cells?

Mark Weiss | EurekAlert!
Further information:
http://www.ksu.edu/

More articles from Health and Medicine:

nachricht PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>